HIV analysis cuts affect progress on work to finish epidemic : NPR

PIEN HUANG, HOST:

Throughout his first time period, President Trump laid out a daring proposal throughout a State of the Union tackle.

(SOUNDBITE OF ARCHIVED RECORDING)

PRESIDENT DONALD TRUMP: My price range will ask Democrats and Republicans to make the wanted dedication to remove the HIV epidemic in the USA inside 10 years. We have now made unimaginable strides, unimaginable.

(APPLAUSE)

HUANG: The Trump administration’s aim of eliminating HIV within the U.S. led to a swell of analysis and funding to review the virus. However within the opening months of his second time period, the Trump administration slashed hundreds of Public Well being jobs and gutted funding for scientific analysis, together with grants and funds for HIV and AIDS analysis. What does this imply for the way forward for HIV analysis within the U.S.? Dr. John Brooks is the previous chief medical officer to the CDC’s division of HIV prevention, and he joins me now. Dr. Brooks, welcome to ALL THINGS CONSIDERED.

JOHN BROOKS: Properly, Pien, thanks. It is a pleasure to be right here, and I respect your consideration to this situation.

HUANG: So initially, are you able to give us a way of the place HIV analysis stood earlier than these cuts?

BROOKS: Properly, you understand, HIV analysis has been in place because the discovery of the virus as the reason for superior HIV illness, which we used to name AIDS. And it is, you understand, made unimaginable strides. We are actually at a spot, resulting from constant funding by means of largely federal assist, that is found wonderful medicine that may assist us each deal with HIV to maintain an individual wholesome but in addition to stop HIV.

HUANG: Had been there any remedies that we have been kind of – you understand, you are speaking about remedies which were developed and are on the market working for individuals. Was there something additionally that was within the works that we’ve not fairly gotten to but?

BROOKS: Yeah, so a few essential issues. To begin with, there was a decadeslong pursuit of an HIV vaccine, and that analysis, in addition to analysis for an HIV treatment, seems to have been canceled. That was largely analysis funded by the NIH. A vaccine can be unimaginable if we might have it – huge public well being affect, gigantic financial advantages, in addition to the scientific developments it’s going to present and has supplied previously. Ditto for an HIV treatment. Secondly, the best way that we may give individuals drugs, each to deal with their an infection and to guard individuals from getting contaminated, are advancing very quickly. A brand new drug, lenacapavir, has just lately been accredited not just for treating but in addition for stopping HIV. And uniquely, it is easy to manage. It is about as simple to manage as a vaccine, and it could possibly shield an individual for as much as six months.

HUANG: So lowering or eliminating HIV requires a two-pronged strategy. There’s the prevention a part of it after which the remedy a part of it. And I am questioning the way you see these cuts impacting every of these approaches.

BROOKS: One of many issues that worries me is that the main target of the present administration with regard to HIV – which by the way is included as a brand new a part of the Administration for a Wholesome America – that HIV bureau or division, no matter it is finally named, appears extremely targeted on simply remedy. However I believe these of us who work in infectious ailments know nicely that remedy is just not going to be the best way you are going to get out of any epidemic. Prevention is a crucial part. And what we’re seeing now could be significantly round prevention analysis and prevention actions, an actual discount in what’s being executed.

HUANG: So given the place we’re, and that, you understand, the truth that Trump’s initiative to remove HIV within the U.S. continues to be being funded, such as you stated, possibly below the brand new Administration for a Wholesome America, at the same time as different HIV analysis is being reduce, do you assume the U.S. can nonetheless attain this aim of eliminating HIV by 2030?

BROOKS: Properly, I am a born optimist, and I’m hopeful. However truthfully, I believe that with the cuts being made in analysis and, specifically, the outstanding and, for my part, draconian cuts being made to federal funding in HIV prevention, are going to result in a rise in new HIV infections nationally. We have now made nice strides on this nation below the president’s first-term signature initiative to remove the HIV epidemic in America. Within the first 4 years that it was in impact, we have seen a 12% decline in new infections nationally and a 19% decline in deaths resulting from HIV.

HUANG: It feels like what you are saying, Dr. Brooks, is that present HIV sufferers will nonetheless have the ability to entry remedy, however you are significantly fearful concerning the prevention a part of it, the prevention of latest individuals from getting HIV. Is that proper?

BROOKS: That is completely proper. You understand, PrEP, this medicine that’s given to stop an infection – it stands for pre-exposure prophylaxis – has made terrific advances. There is a new drug that is on the market that you simply solely should take twice a 12 months by means of injection that may be administered as simply as a vaccine. Nevertheless, the drug could also be obtainable, and it could be very potent, however not all people has entry to it. To succeed in this drug and to get that safety, you might want to bear in mind that you’re in danger for HIV and be taught that you do not have HIV, so the drug can shield you. And then you definately want to have the ability to get to a spot that may administer it, you want to have the ability to afford it, and also you want to have the ability to keep engaged within the type of care that you might want to administer the drug so long as you want it.

HUANG: That is Dr. John Brooks, former chief medical officer to the CDC’s Division of HIV Prevention. Dr. Brooks, thanks for becoming a member of us.

BROOKS: Thanks very a lot. Take care.

Copyright © 2025 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional info.

Accuracy and availability of NPR transcripts could fluctuate. Transcript textual content could also be revised to appropriate errors or match updates to audio. Audio on npr.org could also be edited after its unique broadcast or publication. The authoritative file of NPR’s programming is the audio file.